Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Cell Metabolism|May 13, 2023
Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironmentJie Cheng, Jinxin Yan, Ying Liu, et al.
Frontiers in Oncology|October 17, 2022
B cell deficiency promotes the initiation and progression of lung cancerHan Wu, Chen Chen, Lixing Gu, et al.
Iscience|March 14, 2025
TAF7 directly targets SAA1 to enhance triple-negative breast cancer metastasis via phosphorylating E-cadherin and N-cadherinWanjun Zhang, Jun Wang, Hanning Li, et al.
Iscience|November 29, 2023
JUN mediates glucocorticoid resistance by stabilizing HIF1a in T cell acute lymphoblastic leukemiaZhijie Zhang, Jiangzhou Shi, Qifang Wu, et al.
Experimental Hematology & Oncology|October 17, 2022
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphomaPeiling Zhang, Xiuxiu Yang, Yang Cao, et al.
National Science Review|August 22, 2025
Chemical engineering of γδ T cells with cancer cell-targeting antibodies for enhanced tumor immunotherapyLong Chen, Bo Cheng, Zhanqun Yang, et al.
Nature Cancer|January 13, 2025
ETV7 limits the antiviral and antitumor efficacy of CD8+ T cells by diverting their fate toward exhaustionJie Cheng, Yifeng Xiao, Ting Peng, et al.
Iscience|April 25, 2025
Erratum: JUN mediates glucocorticoid resistance by stabilizing HIF1a in T cell acute lymphoblastic leukemiaZhijie Zhang, Jiangzhou Shi, Qifang Wu, et al.
Blood Science (Baltimore, Md.)|April 11, 2022
Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemiaHaichuan Zhu, Bingjie Dong, Yingchi Zhang, et al.
Signal Transduction and Targeted Therapy|April 11, 2022
Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCTJia Wei, Min Xiao, Zekai Mao, et al.
Pageof 4